What is the primary difference in binding sites between competitive and non-competitive inhibitors?

Competitive inhibitors bind directly to the enzyme's active site, whereas non-competitive inhibitors bind to an allosteric site (a site other than the active site). This difference dictates whether the inhibitor competes with the substrate for the same space.

How does increasing substrate concentration affect the maximum velocity ($V_{max}$) in the presence of a competitive inhibitor?

Increasing substrate concentration allows the reaction to eventually reach the original $V_{max}$. This happens because the higher number of substrate molecules outcompetes the inhibitor for the active sites, eventually filling all available enzymes.

Why does a non-competitive inhibitor lower the $V_{max}$ regardless of substrate concentration?

Because it binds to an allosteric site and causes a conformational change in the active site, making it non-functional. Since the active site shape is altered, adding more substrate cannot force binding, effectively reducing the total number of working enzymes.

What is a common misconception regarding the shape of a non-competitive inhibitor?

A common error is assuming that non-competitive inhibitors must be similar in shape to the substrate. In reality, they have a different shape because they bind to a different part of the enzyme (the allosteric site) rather than the active site.

Why is it incorrect to say that competitive inhibitors 'denature' the enzyme?

Competitive inhibitors only physically block the active site temporarily; they do not break the bonds (like hydrogen or ionic bonds) that maintain the enzyme's tertiary structure. Denaturation involves a permanent loss of shape, whereas reversible inhibition is temporary.

What mistake do students often make when drawing a rate graph for non-competitive inhibition?

Students often draw the curve reaching the same plateau as the uninhibited reaction. For non-competitive inhibition, the curve must plateau at a significantly lower rate because the maximum possible velocity of the reaction is reduced.

Define the term 'Allosteric Site'.

An allosteric site is a specific region on an enzyme, distinct from the active site, where molecules (like non-competitive inhibitors) can bind. Binding at this site typically induces a conformational change that affects the enzyme's activity.

What is 'End-product Inhibition'?

It is a form of negative feedback where the final product of a multi-step metabolic pathway inhibits an enzyme that acts earlier in the pathway. This prevents the over-accumulation of the final product and conserves cellular resources.

Define 'Conformational Change' in the context of enzyme inhibition.

A conformational change is a shift in the three-dimensional tertiary structure of the enzyme protein. In non-competitive inhibition, this change alters the active site's geometry, preventing the substrate from fitting correctly.

How does the 'competition' aspect work in competitive inhibition?

It is a matter of probability based on concentration; both the substrate and inhibitor are constantly colliding with the active site. If substrate concentration is high, the probability of a substrate molecule hitting an empty active site before an inhibitor molecule does increases.

Library Podcasts

Courses

Referral & Rewards

Limiting Factors Affecting Enzymes: Inhibitors

Summary

Enzyme inhibitors are chemical substances that reduce the rate of enzyme-catalysed reactions by interfering with the enzyme's ability to bind with its substrate. They are classified primarily by their binding site and their effect on the enzyme's maximum reaction velocity ( $V_{max}$ ), serving as critical regulators of metabolic pathways through mechanisms like negative feedback.

1. Definition & Core Concepts

Enzyme inhibitors are molecules that bind to enzymes and decrease their activity, effectively slowing down or stopping the conversion of substrates into products. These substances can be reversible or irreversible, though biological regulation typically relies on reversible inhibitors that can detach from the enzyme.
The primary function of inhibitors in a biological context is to provide a mechanism for metabolic control, ensuring that biochemical reactions occur only when needed and at appropriate rates.
Inhibition is categorized based on where the inhibitor binds to the enzyme: either directly at the active site or at an allosteric site (an alternative binding location).

Diagram showing an enzyme with a competitive inhibitor targeting the active site and a non-competitive inhibitor targeting an allosteric site.

2. Competitive Inhibition

3. Non-competitive Inhibition

4. Key Distinctions

5. End-product Inhibition

End-product inhibition is a regulatory mechanism where the final product of a metabolic pathway acts as a non-competitive inhibitor for one of the enzymes at the beginning of the pathway.
This creates a negative feedback loop: as the concentration of the end-product rises, it shuts down its own production by inhibiting the first enzyme, preventing the wasteful accumulation of intermediate substances.
When the levels of the end-product drop, the inhibitors detach from the enzymes, allowing the metabolic pathway to resume activity and maintain a stable internal environment.

6. Exam Strategy & Tips